Therapeutic Application of Endothelial Colony-Forming Cells for Retinal Diseases
In this webinar, Drs. Susumu Sakimoto and Valentina Marchetti discuss their current research on generating human endothelial colony-forming cells (ECFCs) under xeno-free conditions to treat vascular abnormalities in the eye. Vascular abnormalities are a common component of eye diseases that often lead to vision loss. It is possible to use one cell type to rescue another cell type in the face of severe stress. Dr. Susumu will present his study on how human ECFCs injected into the vitreous cavity rescue vaso-obliteration and neurodegeneration in animal models of retinal disease. These results help us understand the mechanism of ECFC-based therapies for ischemic insults and retinal neurodegenerative diseases. Dr. Valentina Marchetti will present a workflow to derive and expand ECFCs under xeno-free conditions using the EC-Cult™-XF ECFC Culture Kit.
Passaging Naive PSC Colonies Derived and Maintained in RSeT™
How to passage naive colonies derived in RSeT™ without transferring irradiated mouse embryonic fibroblasts (iMEFs) to the next passage, and what you can expect during the early stages of reversion
Limitless Potential: Do More with TeSR™
mTeSR™1 is a highly specialized and defined, serum-free and complete cell culture medium, with established protocols for applications ranging from gene editing, bioreactor expansion, to lineage-specific differentiation
RoboSep™-16 Introduction
Introduction of the the RoboSep™-16 instrument, a fully automated cell isolation platform that performs cell isolations from up to 16 samples
Madeline Lancaster on Brain Organoids: Modeling Human Brain Development in a Dish
In this webinar, Dr. Madeline Lancaster, who has done groundbreaking work in the development of cerebral organoid technology, discusses the latest developments in cerebral organoids and provides a comparison of different 3D model systems being used for neurological research.
Research in the Lancaster lab focuses on human brain development using cerebral organoids, a new in vitro model system for neurological development and disease research. The laboratory uses these ‘mini-brains’ to study the most fundamental differences between human and other mammalian species’ brain development - essentially, what makes us human. The lab is also studying cellular mechanisms of, and potential therapeutic avenues for, neurodevelopmental disorders such as autism and intellectual disability.
This webinar is just one of the educational resources on neural organoids that we’ve developed to help you navigate this exciting field. Visit the Neural Organoid Information Hub to learn more.